MedTrace Logo

Study of Glycogen Storage Disease Expression in Carriers

NCT02057731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2016-12-02

No results posted yet for this study

Summary

The purpose of the study is to determine whether carrier status for any type of glycogen storage disease (GSD) predisposes the carrier to GSD markers, like high cholesterol, by testing blood, urine, and saliva samples.

Conditions

  • Glycogen Storage Disease

Interventions

GENETIC

Glycogen Storage Disease markers

Blood and urine tests will be performed on all groups to measure markers of GSD. A saliva DNA test will be used to determine the specific mutation the carrier has or to ensure noncarrier status. A questionnaire will also be filled out.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • David A Weinstein, MD · University of Florida

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02057731 on ClinicalTrials.gov